Skip to main content
NXGL
NASDAQ Life Sciences

Transformative Acquisition Expected to Triple NEXGEL Revenue, Drive Immediate Profitability

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.395
Mkt Cap
$12.123M
52W Low
$0.865
52W High
$3.25
52W Position info
61% above low
Off High info
57% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NXGL sits 61% above its 52-week low of $0.865.

Summary

NEXGEL, Inc. has signed a definitive agreement to license and acquire a transformative portfolio of commercial-stage regenerative biomaterial products from Celularity Inc. This acquisition is expected to approximately triple NEXGEL's annual revenue to about $35 million and make the company immediately profitable upon closing. The portfolio includes six established products with existing insurance reimbursement and a pipeline of three new product filings planned through 2028. Critically, an experienced commercial and scientific team is expected to join NEXGEL, significantly expanding its capabilities. This transaction represents a major strategic shift for NEXGEL, establishing it as a more substantial and profitable entity in the medical technology sector. Investors should monitor the successful closing of the transaction, which is contingent on customary processes and an anticipated $14.9 million in additional financing.

At the time of this announcement, NXGL was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.1M. The 52-week trading range was $0.87 to $3.25. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NXGL - Latest Insights

NXGL
Nov 13, 2026, 9:59 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $3.87
Real-time Price: $3.80 info
Change: -$0.070 (-2%) info
Market Cap: $11.86M info
NXGL
Nov 13, 2026, 9:20 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.39
Real-time Price: $3.80 info
Change: +$0.410 (+12%) info
Market Cap: $11.86M info
NXGL
Nov 12, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $3.80 info
Change: -$0.600 (-14%) info
Market Cap: $11.86M info
NXGL
Nov 11, 2026, 9:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $3.80 info
Change: +$0.220 (+6%) info
Market Cap: $11.86M info
NXGL
Oct 07, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1773
Real-time Price: $3.80 info
Change: Reverse Stock Split info
Market Cap: $11.86M info